Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Sell on the Pop Prospects: July 23 Edition

BY | ETF Database
07/23/2025 | 353 VIEWS
Here is a look at ETFs that currently offer attractive short selling opportunities. The ETFs included in this list are rated as sell candidates for two reasons. First, each of these funds is deemed to be in a downtrend based on the fact that its 50-day moving average is below its 200-day moving average, which are popular indicators for gauging long-term and medium-term trends, respectively. Second, each of these ETFs is also trading above its 20-day moving average, thereby offering a near-term ‘sell on the pop’ opportunity given the longer-term downtrend at hand. Note that this prospects list also features a liquidity screen by excluding ETFs with average trading volumes below the one million shares mark. As always, investors of all experience levels are advised to use stop-loss orders and practice disciplined profit-taking techniques. To get access to all ETF Database premium content, sign up for a free 14-day trial to ETF Database Pro. 28 ETFs made it to the list of sell on the pop prospects this month. Markets finished July with a strong close as tech stocks rallied, with investors digesting the latest inflation data and a wave of earnings reports from big financial firms. Defiance Daily Target 1.75X Long MSTR ETF MSTX and YieldMax MSTR Option Income Strategy ETF MSTY, which provide an exposure to the Strategy (NYSE: MSTR) stock, topped the sell on the pop list, due to substantial Bitcoin purchases made by the company, becoming one of the largest corporate holders of Bitcoin. GraniteShares 2x Long TSLA Daily ETF TSLR, Direxion Daily TSLA Bull 1.5X Shares TSLL, and T-REX 2X Long Tesla Daily Target ETF TSLT made it to the list despite reporting weaker sales in the first half amid tough competition from the Chinese EV makers like BYD. The company is scheduled to report its second-quarter results today, and its stock rose on market anticipation that Big Tech will once again drive S&P 500 earnings growth this quarter. Several REIT-focused funds like Vanguard REIT ETF VNQ and Schwab U.S. REIT ETF SCHH featured on the sell on the pop list. In July, U.S. REITs experienced positive performance driven by a shift in investor sentiment toward dividend-paying stocks, anticipation of potential interest rate cuts, and a generally strong market environment. SPDR S&P Biotech ETF XBI and Direxion Daily S&P Biotech Bull 3x Shares LABU were sell on the pop contenders. Biotech stocks rose in anticipation of upcoming FDA decisions scheduled for July 2025. Biotech stocks may also be experiencing an increase due to a general market rally and advancements in scientific innovation. ProShares Ultra Bloomberg Crude Oil UCO also made it to the list. Seasonal increases in travel and industrial activity have bolstered oil demand. Check out our list of Technology ETFs here To compare this month’s list with the one published on July 3rd, click here. ETFs to Sell on the PopPlease note that this list is updated on a monthly basis. For more ETF analysis, make sure to sign up for our free ETF newsletter. Disclosure: No positions at time of writing.

More Commentary

The Role of Momentum Weighting in Growth Investing
BY | ETF Database
5:43 am ET 08/28/25 | 25 VIEWS
High-Yield Prospects: August 27 Edition
BY | ETF Database
08/27/2025 | 134 VIEWS
Silver & Copper Could Be Critical Minerals: 3 ETFs to Ponder
BY | ETF Database
08/27/2025 | 170 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.